Solution to analyze chiral molecules and biologics.
ENANTIOS AG
Incorporated
22.12.2022Headquarters
ZürichSupport
Modern pharmaceutics are becoming more and more structurally complex, and traditional measurement techniques are slowing down the discovery pipeline. At Enantios we are leveraging new measurement technology to accelerate drug development and discovery and enable more complete quality testing in the manufacturing stage.
News
CE Mark for Swiss medical devices (startupticker.ch)
Swiss startups across industries in the global spotlight (startupticker.ch)
More than 20 Swiss biotech companies to exhibit at Bio Europe (startupticker.ch)
Venture Leaders Biotech 2025 connects Swiss science with the US biotech market (venturelab.swiss)
Enantios: The Venture Leader Biotech innovating in chiral molecule analysis (venturelab.swiss)
Venture Leaders Biotech 2025 kick off at Swiss Biotech Day ahead of Boston roadshow (venturelab.swiss)
Enantios completes first customer delivery (startupticker.ch)
Venture Leaders Biotech 2025 cohort revealed (startupticker.ch)
Venture Leaders Biotech 2025: 10 innovative startups selected for Boston roadshow (venturelab.swiss)
Swiss startups shine worldwide (startupticker.ch)
CHF1.8 million to eliminate critical bottlenecks in traditional drug development (startupticker.ch)
Enantios off to a good start (startupticker.ch)
Milestones news
AG Conversion
